Prevalence and risk factors of significant persistent pain symptoms after critical care illness: a prospective multicentric study.
Details
Serval ID
serval:BIB_4EF231E9CCA8
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Prevalence and risk factors of significant persistent pain symptoms after critical care illness: a prospective multicentric study.
Journal
Critical care
Working group(s)
ALGO-RÉA study group, Atlanréa Group, Société Française d'Anesthésie-Réanimation-SFAR Research Network
Contributor(s)
Yavchitz A., Sigault S., Mazereaud A., Bezu L., Léger M., Evain J.N.
ISSN
1466-609X (Electronic)
ISSN-L
1364-8535
Publication state
Published
Issued date
25/05/2023
Peer-reviewed
Oui
Editor
Yavchitz A Sigault S. Mazereaud A. Bezu L. Leger M. Evain J. N.
Volume
27
Number
1
Pages
199
Language
english
Notes
Publication types: Multicenter Study ; Journal Article
Publication Status: epublish
Publication Status: epublish
Abstract
Prevalence, risk factors and medical management of persistent pain symptoms after critical care illness have not been thoroughly investigated.
We performed a prospective multicentric study in patients with an intensive care unit (ICU) length of stay ≥ 48 h. The primary outcome was the prevalence of significant persistent pain, defined as a numeric rating scale (NRS) ≥ 3, 3 months after admission. Secondary outcomes were the prevalence of symptoms compatible with neuropathic pain (ID-pain score > 3) and the risk factors of persistent pain.
Eight hundred fourteen patients were included over a 10-month period in 26 centers. Patients had a mean age of 57 (± 17) years with a SAPS 2 score of 32 (± 16) (mean ± SD). The median ICU length of stay was 6 [4-12] days (median [interquartile]). At 3 months, the median intensity of pain symptoms was 2 [1-5] in the entire population, and 388 (47.7%) patients had significant pain. In this group, 34 (8.7%) patients had symptoms compatible with neuropathic pain. Female (Odds Ratio 1.5 95% CI [1.1-2.1]), prior use of anti-depressive agents (OR 2.2 95% CI [1.3-4]), prone positioning (OR 3 95% CI [1.4-6.4]) and the presence of pain symptoms on ICU discharge (NRS ≥ 3) (OR 2.4 95% CI [1.7-3.4]) were risk factors of persistent pain. Compared with sepsis, patients admitted for trauma (non neuro) (OR 3.5 95% CI [2.1-6]) were particularly at risk of persistent pain. Only 35 (11.3%) patients had specialist pain management by 3 months.
Persistent pain symptoms were frequent in critical illness survivors and specialized management remained infrequent. Innovative approaches must be developed in the ICU to minimize the consequences of pain.
NCT04817696. Registered March 26, 2021.
We performed a prospective multicentric study in patients with an intensive care unit (ICU) length of stay ≥ 48 h. The primary outcome was the prevalence of significant persistent pain, defined as a numeric rating scale (NRS) ≥ 3, 3 months after admission. Secondary outcomes were the prevalence of symptoms compatible with neuropathic pain (ID-pain score > 3) and the risk factors of persistent pain.
Eight hundred fourteen patients were included over a 10-month period in 26 centers. Patients had a mean age of 57 (± 17) years with a SAPS 2 score of 32 (± 16) (mean ± SD). The median ICU length of stay was 6 [4-12] days (median [interquartile]). At 3 months, the median intensity of pain symptoms was 2 [1-5] in the entire population, and 388 (47.7%) patients had significant pain. In this group, 34 (8.7%) patients had symptoms compatible with neuropathic pain. Female (Odds Ratio 1.5 95% CI [1.1-2.1]), prior use of anti-depressive agents (OR 2.2 95% CI [1.3-4]), prone positioning (OR 3 95% CI [1.4-6.4]) and the presence of pain symptoms on ICU discharge (NRS ≥ 3) (OR 2.4 95% CI [1.7-3.4]) were risk factors of persistent pain. Compared with sepsis, patients admitted for trauma (non neuro) (OR 3.5 95% CI [2.1-6]) were particularly at risk of persistent pain. Only 35 (11.3%) patients had specialist pain management by 3 months.
Persistent pain symptoms were frequent in critical illness survivors and specialized management remained infrequent. Innovative approaches must be developed in the ICU to minimize the consequences of pain.
NCT04817696. Registered March 26, 2021.
Keywords
Humans, Female, Middle Aged, Prevalence, Critical Illness/epidemiology, Critical Illness/therapy, Prospective Studies, Neuralgia, Critical Care, Risk Factors, Critical care, ID-pain, Neuropathic pain, Pain, Post-intensive care syndrome
Pubmed
Web of science
Open Access
Yes
Create date
31/05/2023 8:39
Last modification date
08/08/2024 6:33